FDA Investigator LT Tamara J Henderson

LT Tamara J Henderson has conducted inspections on 82 sites in 5 countries as of 08 Apr 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
82
Last Inspection Date:
08 Apr 2019
Investigator Role:
FDA Investigator
Redica ID:
100009080
Countries of Inspections:
United States of America, India, Italy, Canada, France
FDA Investigators that have inspected at least one site in common with LT Tamara J Henderson:
Adalberto Cajigas, Adam R Cooke, Alan P Kurtzberg, Albert A Salvador, Alice S Tsao, Amy H Ruble, Ana L Kewes, Ana P Barido, Anabel Veiga, Andrea D Charles Julien, Angela E Glenn, Anthony C Warchut, Ashar P Parikh, Ashley A Mutawakkil, Babatunde D Babalola, Barbara M Frazier, Beth F Fritsch, Bill Tacket, Jr, Binh T Nguyen, Bonita S Chester, Brian M Carril, Burnell M Henry, Carl A Huffman, III, Carlos A Ortiz, Carol F Robinson, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Sean T Creighton, CDR Thomas R Berry, PPh, Charles D Brown, Christopher T Smith, Chyla T Hunter, Claudette D Brooks, Constance Y Fears, Courtney A Gilbert, Daphne Santiago, PhD, Dawn M Braswell, Debra J Bennett, Dellarese L Herbert, Demario L Walls, Denise M Digiulio, Devaughn Edwards, Dianiris C Ayala, Dr. Koffi A Amegadje, Earl Echon, Enada F Archibold, Eric M Mueller, PharmD, Eric R Holm, Eric S Weilage, Ethan P Stegman, Frances M Rivera, Frances Mrivera Rosario, Frank J Marciniak, Frank Schwingen, Gabriel R Mclemore, Geraldine D Sanders, Gideon N Esuzor, Gina C Chen, Gina Eng, Hai Lient Phung, Ibad U Khan, Jacqueline D Mitchell, James P Lewis, Jr, James To Neal, Jamirya S Weatherly, Janet B Gray, Jason F Chancey, Jason R Nickelsen, Javier O Vega, Jawaid Hamid, Jennifer A Robinson, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer Lalama, Jennifer M Menendez, Jessica L Pressley, Jessica M Simpson, PhD, Joanne E King, Joanne T Gabay, Johnetta F Walters, José E Meléndez, Joseph F Owens, Joy Rkozlowski Klena, Juliana Falla, Justin H Erickson, Kara D Dobbin, Kathleen D Culver, Katrina B Mosley Sloan, Ladislav Kermet, Lareese K Thomas, Larry K Hampton, Laurie Nelson, Lauryl A Smith, Lawrence S Newsom, Lawrence Thomas, LCDR Matthew J Morrison, LCDR Michael H Tollon, Leah M Andrews, Lesley K Satterwhite, Leslie W Gilbert, Leslie W Jones, Linda K Matheny, Linda M Athey, LT Daveta L Bailey, LT Kimberly M Hull, Luis Mburgos Medero, Marc Balzarini, Marcella D Crook, Marcia Gelber, Marie F Morin, Marisa E Stock, Mary F Bodick, Maureen A Wentzel, Melanie M Walker, Miaja Umaedi, Michele L Obert, Michelle S Dunaway, Mra B Kamberem, Muralidhara B Gavini, PhD, Myoshi M Francis, Nadeem I Chaudhry, Navista C Bolton, Nije A Thomas, Noreen Muñiz, Ormond, Paraluman S Leonin, Patrick L Wisor, Paul A Bonneau, Paul A Licata, Paul H Dakin, Paul W Moy, Penny H Mccarver, Pratik S Upadhyay, DDC, Rachael L Cook, Rachel A Peters, Reba A Gates, Rebecca Rodriguez, Reynolds, Richard K Vogel, Richmond K Yip, Robert C Coleman, Rodney W Lenger, Ronan F King, Ronsha Y Hill, Rozelle G Smith, Russell R Zablan, Safronia Jenkins, Samuel T Walker, Santos E Camara, Sarah E Rhoades, Sarah L Holliday, Satheesh Thomas, Saundrea A Munroe, Sayeeda Hdabe, Seneca D Toms, Sharon Giamberini, Shelby N Turner, Sherbet L Samuels, Sheri L Stephenson, Shirley Brown, Shirley J Berryman, Shirley S Brown, Simone E Pitts, Siramad Sainz Trujillo, Sondra L Phillips, Song Y Lavalais, Sonya M Edmonds, Stephanie D Crockett, Steven B Hertz, Steven J Rush, Susan M Corrales, Susan M Turcovski, Susan O Oladeji, Tajah L Blackburn, Tamara M Felton, Tamika D Cathey, Tammara A Stephens, Tania E Vizcaino, Teresa I Navas, Thomas J Arista, Tomika L Bivens, Tracy R Ball, Trang N Cox, Vanessa E Coulter, Veronica Fuentes, MS, Vicky C Stoakes, Victor Spanioli, Viviana Matta, Whitney F Hook, Xiomara Copeland, Xiujing L Baggett, Yazmith Guzman, Youkeun Kim, Yumi J Hiramine

LT Tamara J Henderson's Documents

Publish Date Document Type Title
February, 2014 FDA 483 Stewart Compounding Pharmacy - Form 483, 2014-02-26
January, 2014 FDA 483 Meta Labs Pharmaceuticals LLC - Form 483, 2014-01-21
August, 2018 FDA 483 HomeChoice Partners dba BioScript Infusion Services - Form 483, 2018-08-17
March, 2017 FDA 483 Partners In Care, Inc. - Form 483, 2017-03-07
August, 2014 FDA 483 International Vitamin Company - Form 483, 2014-08-14
August, 2012 FDA 483 M.D.R. Fitness Corp. - Form 483, 2012-08-03
June, 2016 FDA 483 Partners In Care, Inc. - Form 483, 2016-06-10
July, 2013 FDA 483 Brooklands, Inc. - Form 483, 2013-07-23
October, 2015 FDA 483 Acella Pharmaceuticals, LLC - Form 483, 2015-10-28
April, 2019 FDA 483 Concord, Inc. dba Carlton's Dunwoody Pharmacy - Form 483, 2019-04-12
January, 2016 FDA 483 Concord, Inc. dba Carlton's Dunwoody Pharmacy - Form 483, 2016-01-13
July, 2016 FDA 483 DISHMAN CARBOGEN AMCIS LIMITED - Form 483, 2016-07-08
April, 2016 FDA 483 GlaxoSmithKline LLC - Form 483, 2016-04-21
November, 2013 FDA 483 OXYGEN DEVELOPMENT, L.L.C. - Form 483, 2013-11-22
February, 2015 FDA 483 Shionogi Inc. - Form 483, 2015-02-02
October, 2013 FDA 483 PACKAGE SOLUTIONS LLC - Form 483, 2013-10-03
March, 2014 FDA 483 S.s.s. Company (international) - Form 483, 2014-03-31
January, 2017 FDA 483 H & A Walters Fulfillment Center LLC. - Form 483, 2017-01-20
June, 2013 FDA 483 Therasage, LLC. - Form 483, 2013-06-19
February, 2018 FDA 483 Hospira, Inc. - Form 483, 2018-02-02
September, 2011 FDA 483 Infupharma LLC d.b.a. President Pharmacy - Form 483, 2011-09-27
July, 2015 FDA 483 Avara Aiken Pharmaceutical Services Inc. - Form 483, 2015-07-10
September, 2011 FDA 483 Response Infupharma LLC d.b.a. President Pharmacy - Form 483R, 2011-10-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more